首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1608747

特種注射劑市場：依藥物類型、應用、通路、地區

Specialty Injectable Market, By Drug Type, By Application, By Distribution Channel, By Geography

出版日期: 2024年11月15日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

特種注射劑市場預計到2024年將達到569.2億美元，預計到2031年將達到1,094.5億美元，2024年至2031年的複合年成長率為9.8%。

分析範圍		分析詳情
基準年	2023年	市場規模（2024年）	569.2億美元
實際資料	2019-2023	預測期	2024-2031
預測期複合年成長率（2024-2031）	9.80%	預計金額（2031年）	1094.5億美元

圖：2024 年按地區分類的特種注射劑市場佔有率(%)

特種注射劑是指皮下、靜脈注射、肌肉或玻璃體內給藥的注射藥物療法。這些注射劑用於多種治療領域，包括癌症、風濕病、心血管、自體免疫和中樞神經系統。近年來，生技藥品和標靶治療的進步以及世界老年人口的不斷成長正在推動對特種注射劑的需求。此外，複雜的藥物傳遞機制和功效增強的下一代藥物/器械組合產品的出現也導致了採用率的提高。一些製藥公司正在大力投資專業藥物發現和生物相似藥市場開拓，以滿足新興市場不斷成長的需求。

市場動態

全球特種注射劑市場的成長是由慢性病患病率上升、更容易患各種疾病的老年人口增加、醫療保健成本上升和技術進步所推動的。此外，創新生技藥品的出現和基因療法的採用正在創造利潤豐厚的機會。然而，特殊藥物的高開發成本、嚴格的監管途徑和複雜的冷供應鏈管理帶來了重大挑戰。市場面臨重磅藥物專利到期的威脅。製藥公司正致力於透過研究合作和收購來擴大產品平臺，這可能會在預測期內推動市場成長。

本報告的主要特點

本報告對全球特種注射劑市場進行了詳細分析，以 2023 年為基準年估計了預測期內（2024-2031 年）的市場規模（十億美元）和復合年成長率（CAGR，%）。

它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

基於公司亮點、產品系列、主要亮點、績效和策略等參數的全球特種注射劑市場的主要企業概況。

本報告涵蓋的主要企業包括輝瑞、禮來公司、梯瓦製藥工業公司、諾華公司、Lupin、Mylan NV、Par Pharmaceuticals、Hikma Pharmaceutical PLC、Sargent,Inincludes Pharmaceuticals、Biogen、Dr. Reddy's Laboratories Ltd.、Amgen、Astra Zeneca、太陽製藥工業有限公司

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球特種注射劑市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球特種注射劑市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	56.92 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.80%	2031 Value Projection:	109.45 Bn

Specialty injectable refers to injectable drug therapies that are administered through sites such as subcutaneous, intravenous, intramuscular, and intravitreal routes. These injectables are used across several therapeutic areas including oncology, rheumatology, cardiovascular, autoimmune, and central nervous system indications. Advancements in biologics and targeted therapies along with growing geriatric population globally have boosted demand for specialty injectables in recent years. Moreover, advent of complex drug delivery mechanisms and next-generation drug-device combination products with enhanced efficacy have led to its increased adoption rate. Several pharmaceutical companies are investing heavily in specialized drug discovery and development of biosimilars to cater to growing needs in the market.

Market Dynamics

Global specialty injectable market growth is driven by rising incidence of chronic diseases, growing geriatric population prone to various illnesses, increase in healthcare spending, and technological progressions. Furthermore, emergence of innovative biologics and adoption of gene therapy has created lucrative opportunities. However, high development costs of specialty drugs, stringent regulatory pathways, and complex Cold supply chain management pose significant challenges. The market faces threats from patent expiries of blockbuster drugs. Pharmaceutical players are focusing on widening their product pipelines through research collaborations as well as acquisitions, and this can drive the market growth over the forecast period.

Key features of the study

This report provides in-depth analysis of the global specialty injectable market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global specialty injectable market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Novartis AG, Lupin, Mylan N.V., Par Pharmaceutical, Hikma Pharmaceutical PLC, Sagent Pharmaceuticals, Inc., Biogen, Dr. Reddy's Laboratories Ltd., Amgen Inc., AstraZeneca, Sun Pharmaceutical Industries Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global specialty injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global specialty injectable market

Market Segmentation

By Drug Type Insights (Revenue, USD, 2019 - 2031)
- Small Molecule Drugs
- Biologics
By Application Insights (Revenue, USD, 2019 - 2031)
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Autoimmune Disorders
- Others
By Distribution Channel Insights (Revenue, USD, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer, Inc.
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Lupin
- Mylan N.V.
- Par Pharmaceutical
- Hikma Pharmaceutical PLC
- Sagent Pharmaceuticals, Inc.
- Biogen
- Reddy's Laboratories Ltd.
- Amgen Inc.
- AstraZeneca
- Sun Pharmaceutical Industries Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Specialty Injectable Market, By Drug Type
- Specialty Injectable Market, By Application
- Specialty Injectable Market, By Distribution Channel
- Specialty Injectable Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends

4. Specialty Injectable Market, By Drug Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Small Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Specialty Injectable Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Specialty Injectable Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Specialty Injectable Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020- 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lupin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Par Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceutical PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sagent Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies